Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
449
datasets available to search
ShareScore release 0.9.0
Dataset results
449 results for “ABTS”
An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types
ClinicalTrials.gov study NCT01472003. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
ClinicalTrials.gov study NCT02642432. IPD Sharing: Not stated. Countries: 0. Publications: 6.
Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL
ClinicalTrials.gov study NCT02419560. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)
ClinicalTrials.gov study NCT01995071. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer
ClinicalTrials.gov study NCT00888108. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Activity-Based Therapy and Transcutaneous Spinal Cord Stimulation After Spinal Cord Injury (ABT-TCSCS)
ClinicalTrials.gov study NCT06472986. IPD Sharing: NO. Countries: 1. Publications: 6.
Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL
ClinicalTrials.gov study NCT04515238. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01328626. IPD Sharing: NO. Countries: 2. Publications: 4.
A Study of ABT-165 in Subjects With Solid Tumors
ClinicalTrials.gov study NCT01946074. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT01994837. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage
ClinicalTrials.gov study NCT02032277. IPD Sharing: YES. Countries: 15. Publications: 4.
A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy
ClinicalTrials.gov study NCT01794507. IPD Sharing: NO. Countries: 3. Publications: 2.
Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
ClinicalTrials.gov study NCT00640419. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT00691964. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection
ClinicalTrials.gov study NCT02243280. IPD Sharing: NO. Countries: 0. Publications: 6.
Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1
ClinicalTrials.gov study NCT00850044. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection
ClinicalTrials.gov study NCT02023099. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
ClinicalTrials.gov study NCT01549834. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-981 in Patients With Osteoarthritis of the Knee
ClinicalTrials.gov study NCT01668511. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
ClinicalTrials.gov study NCT00528697. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.